IPO Research Overview
Overview
Symbiotec Pharmalab is a pharmaceutical company engaged in developing and manufacturing active pharmaceutical ingredients, contract development and manufacturing solutions, and complex injectables. The company operates an integrated business model supported by research and development, fermentation, and organic chemistry capabilities. Its active pharmaceutical ingredient portfolio primarily focuses on steroidal products, while its contract development and manufacturing business offers development and manufacturing services for pharmaceutical, nutraceutical, and other life science companies. The company also develops complex injectable products, including double-chamber formats, and leverages its in-house active pharmaceutical ingredient capabilities to support these offerings. Revenue is generated through the sale of active pharmaceutical ingredients, contract development and manufacturing services, and complex injectable products. Its business is supported by backward integration in key raw material processing, large-scale fermentation capacity, and multiple manufacturing facilities, enabling it to serve customers across regulated and global markets.
New to IPO analysis? You may review our structured guides on how IPO allotment works and IPO subscription meaning to better understand demand and allocation mechanics.
Issue Details
Subscription
Live • 12 hrs ago
Min. Investment
Issue Price
₹938 - ₹988
Face Value
-
Issue Size
1757
Fresh Issue
150
Listing At
BSE, NSE
Lead Manager
-
Registrar
-
Lot Size
15 shares
For category-wise quota breakdown such as QIB, HNI, and Retail allocation, refer to our IPO quota structure explanation. Compare this issue with others on our Comparison Engine
Milestones
Subscription
Subscription Progress
Subscription figures represent category demand ratios reported by exchange bidding engines.
Probability Model · Estimate
⚠ Applying for more lots does not improve your odds. SEBI lottery gives each applicant 1 entry regardless of lots applied.
Estimated Allotment Odds
1 in 13
7.7% probability
Retail demand: 12.96x
Subscribed 12.96x. In oversubscribed retail categories, each valid application receives 1 lottery draw entry regardless of lots applied.
GMP (Grey Market Premium)
+18.7% over issue price
GMP is unofficial and indicative only. It does not guarantee listing price or returns.
Trend
Tools
Total Investment
₹14,820
₹988 × 15 shares
Est. Listing Price
₹1,173
+₹185 premium
Est. Total Value
₹17,595
At listing price
Est. Listing Profit
+₹2,775
+18.7% Return
Estimates assume 100% allotment and listing at the indicated GMP rate of ₹185. Grey Market Premium is an unofficial and non-binding indicator. For allotment probabilities, review the Subscription Demand section.
Investment
Investors can bid in multiples of the lot size at the cut-off price.
Allocation
QIB
50%
NII
15%
RII
35%
Employee
-
Issue Summary
Ownership
Promoter shareholding pre and post-issue will be updated once the final capital structure is published.
Contacts
Registrar appointment and registered office contacts will be confirmed in the statutory exchange disclosures.
Documents
Opens SEBI's official filing portal. Search for the company name in results.
Performance
Listing Exchange
BSE, NSE
Listing Price
-
Listing Gain
-
Application
UPI Method (ASBA)
Log in to your broker's app or net banking, navigate to the IPO section, select this IPO, enter lot quantity, and authorise via UPI mandate. Funds are blocked, not debited, until allotment.
ASBA via Net Banking
Log in to your bank's net banking portal, go to the IPO / ASBA section, fill in the bid details, and submit. Your bank will block the required amount automatically.
Allotment & Refund
Allotment status is typically available within 6 days of the IPO close date. Refunds for unallotted bids are credited within 2 working days post allotment.
You may also review the complete IPO allotment process explanation to understand lottery mechanics and refund timelines.
Qualitative Factors
Company Strengths
Company Risks
Legal Disclaimer
Information is sourced from publicly available exchange filings and company offer documents. GMP is unofficial and indicative. IPOCraft does not provide investment advice. Some broker links on this page are affiliate/referral links — IPOCraft may earn a commission if you open an account through them, at no extra cost to you.
Research Before You Apply
